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spread C3 activation and opsonization with C3b. In our hands, CVF
results in increased parasitemia andwe suspect this effect is most likely
due to complement activation and not to complement depletion. InThe role of complement during the invasion of red blood cells by
Plasmodiummerozoites is an enticingﬁeld of study that has great poten-
tial to impact not just our overall understanding of how the parasite
interacts with the human host but also guide future efforts in the devel-
opment of efﬁcacious malarial vaccines. The complexity of parasite and
host interactions during the invasion of red blood cells (RBCs) by the
merozoites and the subsequent growth within the newly invaded host
cell has led to conﬂicting results in the literature. We have recently
reported the enhancing effects of anti-merozite antibodies and comple-
ment interactions at promoting red blood cell invasion and growth by
merozoites.Wehave observed this enhancement using both a tradition-
al invasion assay and the Plasmodium berghei ANKA model of experi-
mental malaria (Biryukov et al., 2016). Our results are in contradiction
to those reported by Boyle et al. (Boyle et al., 2015) who found that in
the presence of complement, anti-merozoite antibodies are effective in
preventing RBC invasion. We attributed these discrepancies in part to
the fact that Boyle et al. useﬁlter-puriﬁedmerozoites as opposed to nat-
urally egressedmerozoites and argue that ﬁlter-puriﬁedmerozoites are
defective and more susceptible to complement attack. In their letter to
the editor, Boyle and Beeson argue that the discrepancy between our re-
sults and theirs cannot be attributed to defectivemerozoites. Wewould
like to thank Boyle and Beeson for taking the time to read our article and
for providing stimulating discussion. We take this opportunity to reply
to their comments.
Boyle and Beeson argue that a recent report by Sack et al. (Sack et al.,
2015) using late arresting genetically attenuated parasites (LAGAP)
supports the role of antibodies and complement in controlling
parasitemia. In this study, the authors report that immunization with
LAGAP induces antibodies against blood stage parasites. Use of cobra
venom factor (CVF) resulted in decreased efﬁcacy of immunization./j.ebiom.2016.05.015, http://
C6860, MC H036, Hershey, PA
. This is an open access article underorder to study the role of complement activation it is best to use
genetically-modiﬁed animals that are deﬁcient in complement factors,
as we did in our study. Further, the passive transfer experiments were
done with serum, not with puriﬁed antibody, using relatively high
amounts per animal (300 μl on day 0, 3, and 5 post-challenge). Use of
puriﬁed antibody and titration experiments would have been more
informative as to the role of antibodies in this system. As mentioned
by Boyle and Beeson, and as discussed in our paper (Biryukov et al.,
2016), Taylor et al. (Taylor et al., 2001) reported that C1q-deﬁcient
mice had a minimal increase in parasitemia upon secondary challenge
with P. chabaudi. We have not tested the P. chabaudi system. One possi-
ble explanation is that complement activation does play a role in
suppressing parasitemia in that system. However, an alternative expla-
nation is that C1qmay act as a signaling ligand for phagocytosis bymac-
rophages (Galvan et al., 2012) and that this ﬁnding may not be related
to downstream complement activation.
Boyle and Beeson state that other studies have failed to see an increase
in invasion when using serum and cite three reports (Campbell et al.,
1979; Chulay et al., 1981; Kennedy et al., 2015). The studies by Campbell
et al. andChulay et al.were carried outwith P. falciparum grown inhuman
RBCs exposed to serum from immune and non-immune Aotusmonkeys.
In these cases, there is a confounding effect of incompatibility between
Aotus serum and human RBCs that makes interpretation difﬁcult. Kenne-
dy et al. did not measure parasitemia directly but measured parasite LDH
as a surrogate. In addition, they allowed the parasites to grow for 32–36 h
as opposed to overnight cultures in our studies.
Finally, Boyle and Beeson argue that if antibodies againstMSP1were
to increase invasion, trials ofMSP1-based vaccineswould have observed
increased parasitemias in vaccinated individuals.We feel this is amisin-
terpretation of our ﬁndings. The ﬁnal outcome of a vaccine, whether ef-
ﬁcacy (inhibition of the pathogen), enhancement, or neither, will
depend on the repertoire of antibodies that are produced and on their
target antigens. Our studies have demonstrated that it is possible for
anti-merozoite antibodies to enhance RBC invasion and this mechanism
can counteract the efﬁcacy of inhibitory antibodies. Thus, if a vaccine is
producing both inhibitory antibodies and antibodies that enhance inva-
sion, the net effect could be efﬁcacy (inhibition), no efﬁcacy, or an en-
hancing effect, depending on the relative amounts of each of the types
of antibodies produced. Hence, the lack of enhancement effect inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tually enhance.
The use of ﬁlter-puriﬁed merozoites has been championed by Boyle
and Beeson and the vast majority of the published studies utilizing this
merozoite puriﬁcationmethod have come from their laboratory or close
collaborators. By their own admission, their assay is “more sensitive
than standard growth inhibition assays” (Boyle et al., 2010) which
could be interpreted as saying that the merozoites are more susceptible
to inhibition than naturally egressed merozoites (Figure 3C and 3D,
(Boyle et al., 2010)). We propose that the increased susceptibility to in-
hibition by antibodies is due to damage from excessive manipulation
during the puriﬁcation process. In addition to ﬁltration, depending on
the protocol used by Boyle and Beeson, this could also include an addi-
tional puriﬁcation step throughmagnetic columns to remove hemozoin.
The damage to the merozoites is reﬂected in the fact that an extremely
high ratio of puriﬁed merozoites to RBCs (~6:1) is needed to attain a
parasitemia of ~1.8% after 24/48 h (Figure S5B, (Boyle et al., 2010)).
Assuming that 16 merozoites egress from one schizont, this merozoite
to RBC ratio is equivalent to incubating target RBCs with a starting
parasitemia of ~27.3% (3 infected RBCs for 8 uninfected RBCs). By con-
trast, our invasion assays can easily achieve a parasitemia of 8% or
higher with a starting parasitemia of 0.5 to 1%.
We hypothesize that ﬁltration is also causing stripping of merozoite
surface proteins. Recentwork has shown thatmerozoites can recruit the
soluble complement regulator factor H (Kennedy et al., 2015; Rosa et al.,
2015).We are concerned that ﬁltration could also strip factor H or other
complement regulators off merozoites making them more susceptible
to complement. However, we are aware that the studies of factor H
used ﬁlter-puriﬁed merozoites. Therefore, if stripping does occur, it
does not lead to 100% removal of surface antigens.
Despite its shortcomings, we believe that the use of ﬁlter-puriﬁed
merozoites can be a useful tool in the understanding of host-parasite in-
teractions. However,we need to understand its limitations. In our hands
(Biryukov et al., 2016), ﬁlter-puriﬁed merozoites are not equivalent to
naturally egressed merozoites that are allowed to invade withinminutes. Therefore, in our opinion, any invasion data that utilizes
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